A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Endometrial Cancer
Related studies linked through entity extraction aliases.